Viewing Study NCT00064051


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-01-24 @ 10:24 PM
Study NCT ID: NCT00064051
Status: COMPLETED
Last Update Posted: 2013-08-02
First Post: 2003-07-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Sponsor: Vion Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage II pancreatic cancer View
None stage III pancreatic cancer View
None recurrent pancreatic cancer View
None stage IV pancreatic cancer View